logo

For the Inventor, By the Inventor

Lawrenceville, NJ, United States of America

Adare Pharmaceuticals, Inc.


USPTO Granted Patents = 30

% Expired Patents = 40.0



Trademarks = 6

Forward Citations = 256

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Gopi M Venkatesh (28 out of 62 patents)

silverMedal Jin-Wang Lai (7 out of 15 patents)

bronzeMedal James M Clevenger (4 out of 13 patents)

4.  Fredric Cohen (3 out of 12 patents)

5.  Stephen Perrett (3 out of 9 patents)

6.  Michael A Gosselin (3 out of 7 patents)

7.  Michelle Schilling (3 out of 3 patents)

8.  Ken Kangyi Qian (3 out of 10 patents)

9.  Luigi Boltri (2 out of 10 patents)

10.  Flavio Fabiani (2 out of 7 patents)

11.  Christian Stollberg (1 out of 3 patents)

12.  Brian A Meltzer (1 out of 6 patents)

13.  Gail M Comer (1 out of 7 patents)

14.  Italo Colombo (1 out of 1 patent)

15.  Shyam Vangala (1 out of 3 patents)


Core Competencies:
Drug Delivery
Taste-Masked Compositions
Pulsatile Release
Orally Disintegrating Tablets
Corticosteroids
Weakly Basic Drugs
Eosinophilic Esophagitis
Modified Release Dosage
Amphetamine Composition
Microcapsules
Analgesics
Skeletal Muscle Relaxants

30 patents:

1. 12151028 - Drug delivery systems comprising solid solutions of weakly basic drugs (2024-11-26),
2. 11896562 - Oral amphetamine composition (2024-02-13),
3. 11452689 - Taste-masked pharmaceutical compositions (2022-09-27),
4. 11160772 - Oral amphetamine composition (2021-11-02),
5. 11147772 - Timed, pulsatile release systems (2021-10-19),
6. 10952971 - Taste-masked pharmaceutical compositions with gastrosoluble pore-formers (2021-03-23),
7. 10864166 - Drug delivery systems comprising solid solutions of weakly basic drugs (2020-12-15),
8. 10568832 - Taste-masked pharmaceutical compositions (2020-02-25),
9. 10500161 - Timed, pulsatile release systems (2019-12-10),
10. 10471071 - Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis (2019-11-12),
11. 10471017 - Taste-masked pharmaceutical compositions with gastrosoluble pore-formers (2019-11-12),
12. 10441554 - Oral amphetamine composition (2019-10-15),
13. 10130580 - Taste-masked pharmaceutical compositions (2018-11-20),
14. 10105315 - Methods of treating eosinophilic esophagitis (2018-10-23),
15. 10045946 - Timed, pulsatile release systems (2018-08-14),
Adare Pharmaceuticals, Inc. is a specialized pharmaceutical company based in Lawrenceville, NJ, focused on developing innovative drug delivery solutions and specialty pharmaceuticals. The company leverages advanced technologies to enhance the efficacy and safety of medications, particularly in areas such as pain management and gastrointestinal health. With a commitment to improving patient outcomes, Adare collaborates with healthcare professionals and organizations to address unmet medical needs through its tailored therapeutic approaches.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Adare Pharmaceuticals, Inc.
30 Patents

#6 in Lawrenceville, NJ

#450 in New Jersey

#11,249 in US

#21,840 in the World

Lawrenceville, NJ (US)
Lawrenceville, NJ, United States of America

Adare Pharmaceuticals, Inc.

Forward Citations = 256

25 inventors:

goldMedal Gopi M Venkatesh (28 out of 62 patents)

silverMedal Jin-Wang Lai (7 out of 15 patents)

bronzeMedal James M Clevenger (4 out of 13 patents)

4.  Fredric Cohen (3 out of 12 patents)

5.  Stephen Perrett (3 out of 9 patents)

Please report any incorrect information to [email protected]
Loading…